MXPA02012911A - Compuestos de rutenio (ii) para el uso en terapia del cancer. - Google Patents

Compuestos de rutenio (ii) para el uso en terapia del cancer.

Info

Publication number
MXPA02012911A
MXPA02012911A MXPA02012911A MXPA02012911A MXPA02012911A MX PA02012911 A MXPA02012911 A MX PA02012911A MX PA02012911 A MXPA02012911 A MX PA02012911A MX PA02012911 A MXPA02012911 A MX PA02012911A MX PA02012911 A MXPA02012911 A MX PA02012911A
Authority
MX
Mexico
Prior art keywords
cancer
compounds
ruthenium
therapy
saturated
Prior art date
Application number
MXPA02012911A
Other languages
English (en)
Spanish (es)
Inventor
Haimei Chen
Original Assignee
Univ Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Glasgow filed Critical Univ Glasgow
Publication of MXPA02012911A publication Critical patent/MXPA02012911A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA02012911A 2000-06-30 2001-06-26 Compuestos de rutenio (ii) para el uso en terapia del cancer. MXPA02012911A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016052.3A GB0016052D0 (en) 2000-06-30 2000-06-30 Ruthenium (II) compounds
PCT/GB2001/002824 WO2002002572A1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer

Publications (1)

Publication Number Publication Date
MXPA02012911A true MXPA02012911A (es) 2004-07-30

Family

ID=9894730

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012911A MXPA02012911A (es) 2000-06-30 2001-06-26 Compuestos de rutenio (ii) para el uso en terapia del cancer.

Country Status (14)

Country Link
US (1) US6936634B2 (enExample)
EP (1) EP1294732B1 (enExample)
JP (1) JP2004502696A (enExample)
AT (1) ATE273985T1 (enExample)
AU (1) AU2001267687A1 (enExample)
BR (1) BR0112122A (enExample)
CA (1) CA2414446A1 (enExample)
DE (1) DE60105028T2 (enExample)
DK (1) DK1294732T3 (enExample)
ES (1) ES2227225T3 (enExample)
GB (1) GB0016052D0 (enExample)
MX (1) MXPA02012911A (enExample)
PT (1) PT1294732E (enExample)
WO (1) WO2002002572A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1224192B1 (en) * 1999-10-27 2005-08-31 The University Court, The University Of Edinburgh Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
AU2002346686A1 (en) * 2001-12-07 2003-06-23 Intermune, Inc. Compositions and method for treating hepatitis virus infection
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds
AU2004234127A1 (en) 2003-04-30 2004-11-11 The University Court Of The University Of Edinburgh Ruthenium (II) complexes for the treatment of tumors
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
CN101851256B (zh) * 2010-04-30 2013-01-09 广东药学院 一种以柔性碳链联接的钌(ⅱ)卟啉配合物及其制备方法和应用
CN101863925B (zh) * 2010-05-21 2012-08-29 广东药学院 一种芳基钌(ⅱ)配合物及其制备方法和应用
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980472A (en) 1983-06-23 1990-12-25 American Cyanamid Company Method of making (3-amino-1H-pyrazol-4-yl) (aryl)methanones
AU570826B2 (en) 1984-07-24 1988-03-24 Asta-Pharma Aktiengesellschaft Ruthenium compounds having a tumor inhibiting activity
WO1986000804A1 (fr) 1984-07-24 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Compositions de ruthenium a effet inhibiteur de tumeurs
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
US5225556A (en) 1985-01-18 1993-07-06 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and for A-DNA; chiral metal complexes as Z-specific antitumor agents and as double strand cleavers
US4699978A (en) 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
AU4017695A (en) 1994-10-28 1996-05-23 Procept, Inc. Ruthenium complexes and their use as immunosuppressive agents
JPH11209314A (ja) 1997-09-30 1999-08-03 Takasago Internatl Corp シクロオクタジエン類の製造方法
JP3488103B2 (ja) * 1998-11-12 2004-01-19 高砂香料工業株式会社 ４−メチル−５−ヘキセン−１−アールを含有する香料組成物
GB0028025D0 (en) 2000-11-17 2001-01-03 Univ York Compounds

Also Published As

Publication number Publication date
DK1294732T3 (da) 2004-12-06
US20040029852A1 (en) 2004-02-12
PT1294732E (pt) 2004-12-31
ES2227225T3 (es) 2005-04-01
BR0112122A (pt) 2003-05-13
US6936634B2 (en) 2005-08-30
JP2004502696A (ja) 2004-01-29
DE60105028D1 (de) 2004-09-23
WO2002002572A1 (en) 2002-01-10
ATE273985T1 (de) 2004-09-15
EP1294732A1 (en) 2003-03-26
DE60105028T2 (de) 2005-08-18
EP1294732B1 (en) 2004-08-18
CA2414446A1 (en) 2002-01-10
AU2001267687A1 (en) 2002-01-14
GB0016052D0 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
DE60112974D1 (en) Carbolinderivate
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
TW200505434A (en) Therapeutic treatment
MXPA05012421A (es) Tratamiento sinergistico de cancer usando inmunomeros junto con agentes quimioterapeuticos.
ATE461217T1 (de) Glp-1-verbindungen
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
GEP20053688B (en) Substituted-Triazolopyrimidines as Anticancer Agents
MY138883A (en) Use of asiatic acid for treatment of cencer
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
DE60216233D1 (en) Carbolinderivate
MXPA03002911A (es) Compuestos quimicos.
IL150125A0 (en) Novel compounds
GB0018951D0 (en) Novel compounds
DK1294732T3 (da) Ruthenium (II)-forbindelser til anvendelse i cancerterapi
MXPA02012470A (es) Inhibidores de fosfodiesterasa especificos para gmp ciclico.
IL135825A0 (en) Use of mirtazapine for treating sleep apneas
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
GB0215526D0 (en) Anticancer compounds
MXPA02012472A (es) Compuestos quimicos.
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
GB0027705D0 (en) Novel compounds
PT1303520E (pt) Compostos terapêuticos e métodos
TW200504051A (en) Novel acridine derivatives and their use as medicaments
SE0004827D0 (sv) Therapeutic compounds
SI1003554T1 (en) Proton pump inhibitor in therapeutic combination with antibacterial substances

Legal Events

Date Code Title Description
FG Grant or registration